A new article in the Journal of the American Medical Association (JAMA) showing how Merck used ghostwriters to hide of the perils of Vioxx (http://jama.ama-assn.org/cgi/content/full/299/15/1800) is only one example of how ghostwritten academic articles can impact patient safety, according to a Policy Brief released today by The Prescription Project.

The Prescription Project, a national campaign to end the influence of pharmaceutical marketing on physician prescribing decisions, today applauded U.S.